Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Inflamm Res ; 54(7): 289-94, 2005 Jul.
Article in English | MEDLINE | ID: mdl-16134058

ABSTRACT

OBJECTIVE AND DESIGN: The purpose of the study was to investigate the putative role of soluble thrombomodulin (sTM) in severe carotid artery stenosis. MATERIALS AND METHODS: We prospectively studied 64 patients who were undergoing carotid endarterectomy (2001-2003). Plasma sTM concentration was determined in each patient before surgery and at 14 months postsurgery. -308 TNF-alpha promoter polymorphism was also determined. RESULTS: Strong negative correlation was found between the preoperative duplex scan values and the plasma sTM concentrations (R = -0.418, p = 0.0006). Patients with 308 A TNF-alpha genotype had significantly lower (p = 0.0415) preoperative sTM values than their counterparts with no such polymorphism. Soluble TM concentrations measured in plasma samples taken at the end of the postsurgical follow-up period of 14 months duration were significantly higher compared to the preoperative values (p < 0.0001). CONCLUSIONS: Our present findings indicate that sTM may be adsorbed to the atherosclerotic plaques or inflamed endothelium in carotid arteries. The pathological significance of this adsorption remains to be determined.


Subject(s)
Carotid Stenosis/blood , Thrombomodulin/blood , Adsorption , Aged , Aged, 80 and over , Alleles , Arteriosclerosis/pathology , Carotid Arteries/pathology , Dose-Response Relationship, Drug , Down-Regulation , Endothelium, Vascular/pathology , Female , Follow-Up Studies , Genotype , Humans , Inflammation , Male , Middle Aged , Polymorphism, Genetic , Postoperative Period , Promoter Regions, Genetic , Smoking , Thrombomodulin/metabolism , Time Factors , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/metabolism
2.
Eur J Clin Invest ; 35(2): 104-11, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15667581

ABSTRACT

BACKGROUND: This study aimed to investigate independent and additive predictive effects of raised C-reactive protein (CRP) levels and decreased total cholesterol levels on mortality in patients with chronic coronary artery disease (CAD). Low total cholesterol (TC) levels are associated with worsened survival in chronic and acute diseases. Elevated CRP level is an important predictor of vascular events and mortality in patients with CAD. Potential inhibition of immune activation by circulating lipoproteins could be a link between cholesterol and inflammatory markers. MATERIALS AND METHODS: A group of 387 patients (median age 59 years) with CAD and with or without severe heart failure (HF) were followed for a median of 5.06 years. Serum total cholesterol and CRP concentrations were measured at enrollment. RESULTS: The relationship between lipoproteins, CRP and survival was explored. High CRP concentrations were in significant association with severity of HF and predicted worsened survival in patients with CAD (hazard ratio 5.214, 95% CI 1.762-15.427). The association between CRP levels and mortality was independent of potential confounding factors such as age, body-mass index, severity of HF, smoking habits, hypertension and TC levels. The prediction of mortality by low TC levels was significant (hazard ratio 2.932, 95% CI 1.021-8.422). Furthermore, patients with increased CRP and decreased TC (additive predictive effect) phenotype had 11.714-times higher risk (95% CI 2.619-52.385) of being nonsurvivors than patients with low CRP/high TC. CONCLUSIONS: High CRP levels and low TC concentrations are independent and additive predictors of mortality in patients with CAD. Our data indicate that joint analysis of circulating lipoproteins and inflammatory biomarkers may improve prediction of survival in patients with CAD.


Subject(s)
C-Reactive Protein/analysis , Cholesterol/blood , Coronary Artery Disease/blood , Aged , Coronary Artery Disease/mortality , Female , Humans , Male , Middle Aged , Predictive Value of Tests , Risk Factors
3.
Inflamm Res ; 53(11): 631-5, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15693612

ABSTRACT

OBJECTIVE AND DESIGN: To study changes in the levels of two acute phase proteins, plasma fibrinogen and serum C-reactive protein (hs-CRP) in patients with severe carotid stenosis after eversion endarterectomy. MATERIAL AND SUBJECTS: A total of 117 consecutive patients who underwent eversion endarterectomy were included in the study. Blood samples for acute phase protein measurement were taken before operation as well as 5.7 weeks and 13.8 months (median) post-surgery. Plasma fibrinogen and serum hs-CRP concentrations were promptly determined. RESULTS: During the follow-up period sharp, highly significant (p < 0.0001) drop occurred in the serum concentrations of both acute phase proteins. The drop in the hs-CRP levels during the follow up period was mainly due to decrease in patients with highest baseline CRP levels. CONCLUSIONS: Our present findings indicate that removal of atherosclerotic plaques from the carotid arteries markedly decreases the production of two acute phase proteins due to the decrease of the inflammatory burden or the removal of the advanced plaques able to produce these proteins.


Subject(s)
C-Reactive Protein/analysis , Carotid Stenosis/blood , Carotid Stenosis/surgery , Endarterectomy, Carotid , Fibrinogen/analysis , Arteritis/blood , C-Reactive Protein/metabolism , Carotid Stenosis/metabolism , Case-Control Studies , Endarterectomy, Carotid/methods , Female , Fibrinogen/metabolism , Humans , Male , Middle Aged , Recurrence , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...